wellrank.ai
Sign In
Prempro logo

Prempro

First cited by AI Jun 17, 2026
premproxy.com ↗

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

Prempro is losing the AEO war.

Not cited in a single tracked AI answer since Oct 22, 2026, down from a peak of 33% visibility in menopause and women's health on Oct 1, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Prempro, through Oct 28, 2026.

0.0%

Last cited Oct 22, 2026 · peak 33% on Oct 1

By engine

Where Prempro is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 4 positive mentions
  • 46 neutral
  • 2 mixed or cautious

Recent AI answers mentioning Prempro

ChatGPTOct 19, 2026, 11:32 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

I'm sorry you’re dealing with that — hot flashes and poor sleep are very common around perimenopause/menopause, but there are several effective options. Which are best depends on how severe the hot flashes and sleep problems are, your medical history (especially prior breast cancer, blood clots, stroke, heart disease, liver disease), whether you still have a uterus, and what medicines you’re taking. Summary below of the main options, why they help, and examples of specific products/services. 1) First-line — Hormone therapy (most effective for hot flashes) What: Systemic estrogen relieves hot flashes quickly and often restores sleep by reducing night sweats. If you still have a uterus, estrogen is given with a progestogen to protect the uterine lining. Brands/examples: transdermal estradiol patches (Vivelle‑Dot, Climara) or low‑dose oral estradiol (Estrace). Combined estrogen/progestin options include Prempro (conjugated estrogen + medroxyprogesterone) or oral micronized progesterone (Prometrium) added when needed. Why choose it: Best evidence for rapid, large reduction in vasomotor symptoms and improvement in sleep. Risk/benefit is more favorable if started before age ~60 or within 10 years of menopause, but individual factors matter. Important cautions: Not recommended if you have current/recent breast cancer, history of VTE (blood clots), active liver disease, or certain cardiovascular conditions. Discuss risks and duration with your clinician. 2) Non-hormonal prescription options (if hormones are not appropriate or preferred) Paroxetine 7.5 mg (brand: Brisdelle) — the only FDA-approved nonhormonal drug for hot flashes. Effective at reducing frequency and severity. Important: paroxetine interferes with tamoxifen (used in breast cancer) and should be avoided if you’re on tamoxifen. SNRIs/SSRIs (off‑label): venlafaxine (Effexor), desvenlafaxine (Pristiq), escitalopram — often reduce hot flashes and help mood/anxiety. Gabapentin (Neurontin): helpful for night-time hot flashes and sleep; often given 300 mg at bedtime or divided doses. Clonidine (Catapres): modest benefit for some women. Oxybutynin (Ditropan): emerging evidence for hot flashes (off‑label). Why choose them: Useful when hormones are contraindicated (e.g., breast cancer history) or if you prefer nonhormonal treatment. Cautions: Each drug has side effects — e.g., paroxetine has sexual side effects and drug interactions; gabapentin causes drowsiness/dizziness; SNRIs can raise blood pressure (venlafaxine). 3) Treatments specifically for insomnia / sleep problems Cognitive Behavioral Therapy for Insomnia (CBT‑I): first‑line for chronic insomnia and safe long-term. Strong evidence it improves sleep continuity and daytime function. Services/apps: Sleepio (Big Health) and Somryst (Pear Therapeutics) are evidence-based digital CBT‑I programs; CBT‑I trained therapists can be found via the Society of Behavioral Sleep Medicine. Short‑term medication options for sleep (use with caution): zolpidem (Ambien), eszopiclone (Lunesta), low‑dose doxepin (Silenor). Consider melatonin or prescription ramelteon (Rozerem) for sleep‑onset problems. Why choose CBT‑I: durable benefit without medication risks. Medications can help short-term but have risks of dependence, next-day drowsiness, and falls (more concern as people age). 4) Lifestyle, behavioral, and self-care measures Sleep hygiene: consistent schedule, cool bedroom, limit caffeine/alcohol, reduce screens before bed. Night-sweat measures: sleep in a cool room, breathable bedding, layered clothing for quick removal, fans. Relaxation and paced breathing: slow breathing and relaxation techniques can reduce hot flash severity. Weight maintenance, exercise, and stopping smoking may help overall symptoms. 5) Complementary/alternative approaches (mixed evidence) CBT for menopause / mindfulness-based stress reduction can reduce hot flash bother. Acupuncture, yoga, and paced breathing have modest or mixed evidence. Herbal supplements (black cohosh, soy/phytoestrogens) show inconsistent benefits; supplement quality and safety vary — discuss before trying, especially if you have hormone-sensitive cancer. 6) Evaluation and next steps See your primary care doctor, gynecologist, or a menopause specialist to: Review medical history and meds (look for interactions, e.g., tamoxifen + paroxetine). Decide whether hormone therapy is safe and appropriate. Assess for other causes of poor sleep (sleep apnea, restless legs, mood disorders). Consider labs or pregnancy test if relevant and discuss monitoring while on HT. If your main problem is insomnia, ask about CBT‑I (Sleepio, Somryst, or a local CBT‑I therapist). If you want quick symptom relief and have no contraindications, discuss short‑term hormone therapy with a plan for follow-up and reassessment. If you’d like, I can: Help you prepare a short list of questions to bring to your clinician. Suggest which option might fit best given any medical history you tell me (e.g., breast cancer, blood clots, current meds). Point to resources from the North American Menopause Society for more reading. Would you like help preparing questions for your doctor, or tell me a bit about your medical history and priorities so I can suggest a more specific plan?

Mentioned in position 4 of 19

Read full answer with sources →
ChatGPTOct 16, 2026, 11:32 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” means the hormones have the same chemical structure as the hormones your body makes (usually estradiol, progesterone, testosterone). “Standard” HRT often uses products that are different molecules (conjugated equine estrogens, synthetic progestins) or FDA-approved forms of estradiol/progesterone. The main practical differences are source/labeling, customization, regulation, and the evidence base — not a proven safety advantage for bioidentical compounded preparations. What people mean by each term Bioidentical hormones Chemically identical to human hormones (e.g., 17β‑estradiol, micronized progesterone). Can be prescribed as FDA‑approved products (oral estradiol, estradiol patches, Prometrium for progesterone) or as custom‑compounded mixtures from compounding pharmacies (“custom BHRT”). Standard HRT Historically refers to the classic, FDA‑approved menopausal hormone therapies such as conjugated equine estrogens (Premarin) and synthetic progestins (medroxyprogesterone acetate, Provera). Today many FDA‑approved therapies are bioidentical estradiol and micronized progesterone too — so “standard” overlaps with “bioidentical” depending on the product. Key practical differences Chemical identity: Bioidentical estradiol/progesterone = same molecules as endogenous hormones. Synthetic progestins and conjugated equine estrogens are different molecules. Regulation and quality control: FDA‑approved products have manufacturing controls, standardized dosing, and clinical trial data. Compounded bioidentical prescriptions are not FDA‑approved, can vary in dose/consistency, and have less rigorous safety/efficacy data. Customization: Compounding allows customized dosages, forms, and combinations (often promoted as an advantage). FDA products come in standard doses and forms with known pharmacology. Evidence on safety/efficacy: FDA‑approved estradiol and micronized progesterone have clinical data. Some synthetic progestins (e.g., medroxyprogesterone) were linked in WHI and other studies to different risks (breast cancer signal, cardiovascular effects) depending on formulation and duration. There is no high‑quality evidence that compounded “BHRT” is safer or more effective than comparable FDA‑approved bioidentical products; claims of being more “natural” do not equal safer. Route matters: oral vs transdermal vs vaginal affects liver first‑pass, clotting risk, and symptom control. For example, transdermal estradiol patches (Vivelle‑Dot, Climara) may have lower risk of venous thromboembolism than oral estrogen in some studies. Safety points Risk profile depends on your age, time since menopause, dose, formulation, and whether a progestogen is used if you have a uterus. Common risks to discuss with your clinician: breast cancer risk, stroke, heart disease, blood clots, and side effects. Because compounded products are not FDA‑regulated, they may have variable potency/sterility. If you consider compounding, use a pharmacy accredited by an independent body (PCAB) and discuss why an FDA‑approved product can’t meet your needs. Examples (brands and why) FDA‑approved bioidentical options Estrace (oral estradiol) — standard, well‑studied oral estradiol. Climara or Vivelle‑Dot (transdermal estradiol patches) — transdermal delivery, may lower first‑pass liver effects and clot risk. Estring (vaginal estradiol ring) — local therapy for vaginal symptoms with low systemic exposure. Prometrium (micronized progesterone) — FDA‑approved, bioidentical progesterone option for endometrial protection; differs from synthetic progestins. Examples of “standard” (non‑bioidentical/synthetic) products Premarin (conjugated equine estrogens) and Prempro (Premarin + medroxyprogesterone acetate) — historically common HRT formulations; chemically distinct from human estradiol/progesterone. Provera (medroxyprogesterone acetate) — a synthetic progestin often used with estrogen. If considering compounding (only when necessary) Use an accredited compounding pharmacy (look for PCAB accreditation or USP compliance). Examples in the U.S. that many clinicians use include Wedgewood Pharmacy and Belmar Pharmacy — but check current accreditation, reviews, and ask your clinician for local recommendations. Where to get evidence‑based help Consider consultation with a NAMS (North American Menopause Society)‑aware clinician, a menopause clinic (e.g., Mayo Clinic or Cleveland Clinic menopause programs), or a board‑certified OB/GYN or endocrinologist experienced in menopause care. How to decide what’s best for you Get a medical evaluation: symptoms, medical history, breast cancer/VTE/stroke/heart disease risk, and personal preferences. If you have a uterus, you generally need a progestogen along with systemic estrogen to protect the endometrium. Prefer FDA‑approved bioidentical options when available. Consider compounding only if a clinically important individualized dosage or form cannot be obtained as an approved product and use an accredited compounding pharmacy. Follow-up and monitoring: start with the lowest effective dose, reassess symptoms and side effects, and review risks periodically. Bottom line “Bioidentical” describes molecular identity; “standard HRT” describes traditional formulations and includes both bioidentical and non‑bioidentical products. FDA‑approved bioidentical products (estradiol, micronized progesterone) have known quality and evidence. Compounded BHRT is customizable but less regulated and not proven safer. Discuss options with a clinician who can tailor the choice to your health profile and risk factors. If you want, tell me your symptoms, age, and any medical history and I can summarize options and what to discuss with your clinician.

Mentioned in position 3 of 10

Read full answer with sources →
ClaudeOct 11, 2026, 11:31 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone therapies that may include: Synthetic hormones (like medroxyprogesterone acetate) or animal-derived hormones Brands like Premarin (conjugated equine estrogens), Provera, or Prempro Standardized, tested doses with well-documented safety data Bioidentical Hormones These have a molecular structure identical to hormones your body produces naturally Two main types: FDA-approved bioidenticals - brands like Estrace, Prometrium, Vivelle-Dot, Divigel - these are well-tested and regulated Compounded bioidenticals - custom-mixed by compounding pharmacies, often prescribed by integrative medicine doctors - less regulated and less evidence-based Key Considerations Factor Standard HRT Bioidentical Regulation Strong FDA oversight Varies widely Evidence Extensive studies More limited Customization Standardized Can be tailored Cost Often insurance-covered Often out-of-pocket My Recommendation Start with FDA-approved bioidenticals like Prometrium or Vivelle-Dot - you get the "natural" molecular structure with regulatory safety backing. Always consult a gynecologist or endocrinologist before deciding.

Mentioned in position 3 of 7

Read full answer with sources →
ClaudeOct 6, 2026, 11:31 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone medications that may contain: Synthetic hormones (like medroxyprogesterone acetate) Animal-derived hormones (like Premarin, made from pregnant mare urine) Chemically modified versions different from your body's natural hormones Popular brands: Premarin, Prempro, Provera Bioidentical Hormones These have a molecular structure identical to hormones your body produces naturally (estradiol, progesterone, testosterone). Two categories: FDA-approved bioidenticals - rigorously tested for safety and dosing Compounded bioidenticals - custom-mixed by pharmacies, less regulated Recommended Options FDA-approved bioidenticals (generally safer choice): Estrace (estradiol) - widely trusted oral option Vivelle-Dot - estradiol patch, popular for steady delivery Prometrium - natural progesterone, well-studied Bijuva - combined bioidentical option Compounding pharmacies like Women's International Pharmacy are reputable if you need customized dosing. Important Note ⚠️ Consult a doctor or menopause specialist (look for NAMS-certified practitioners) before choosing - individual health history matters significantly.

Mentioned in position 2 of 8

Read full answer with sources →
ChatGPTOct 1, 2026, 11:31 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical hormones” means hormones whose molecular structure is identical to the hormones your body makes (examples: 17β‑estradiol, micronized progesterone). They can be either FDA‑approved commercial products or custom‑made (compounded) preparations. “Standard” or “conventional” HRT usually refers to the commonly prescribed pharmaceutical hormone preparations, which may be bioidentical (estradiol, micronized progesterone) or non‑bioidentical/synthetic (conjugated equine estrogens, synthetic progestins like medroxyprogesterone acetate). The main differences are the exact hormone molecules used, how they are produced/regarded by regulators, and the evidence base about safety and quality. Key differences (concise) Molecule: Bioidentical = chemically identical to human hormones (e.g., 17β‑estradiol, progesterone). Non‑bioidentical (“synthetic”) HRT uses different molecules (e.g., conjugated equine estrogens like Premarin, or progestins like medroxyprogesterone/Provera). Source and formulation: FDA‑approved bioidentical products are manufactured with quality controls (examples below). “Compounded bioidentical hormones” are mixed individually by compounding pharmacies to custom strengths/combination and are not individually FDA‑approved. Regulation and quality: FDA‑approved pharmaceuticals (Estrace, Climara, Vivelle‑Dot, Prometrium, etc.) have standardized dosing, potency testing, and labeled safety information. Compounded products may vary in potency/consistency and have less standardized oversight—use accredited compounding pharmacies if choosing this route. Evidence and safety: There’s no convincing evidence that compounded bioidentical hormones are inherently safer or more effective than FDA‑approved HRT. Risks (blood clots, stroke, breast cancer risk, endometrial hyperplasia if estrogen is unopposed) generally relate to hormonal exposure, route, dose, and individual risk factors. Some formulations/routes (e.g., transdermal estradiol, vaginal low‑dose estrogen, micronized progesterone) may have different risk profiles. Clinical points to know Routes matter: oral vs transdermal vs vaginal. Transdermal estradiol may have lower effect on clotting factors and possibly lower VTE risk than some oral estrogens. Progestogen choice matters: micronized progesterone (Prometrium) behaves differently than synthetic progestins (MPA/Provera) and some data suggest differences in side‑effect and possibly cardiovascular/breast risks, but evidence is evolving. Testing: routine saliva “hormone tests” are not recommended for dosing menopausal HRT; blood levels don’t reliably reflect tissue effects. Dosing is usually symptom‑directed and individualized, with monitoring for side effects and routine screening as appropriate (mammography, blood pressure, etc.). Vaginal/local estrogen: low‑dose local products (Vagifem, Estring, local estradiol creams) are effective for urogenital symptoms with minimal systemic exposure for most women. Examples of commonly prescribed, FDA‑approved products (for discussion with your clinician) Estradiol (oral): Estrace — FDA‑approved estradiol pill. Estradiol patches: Climara, Vivelle‑Dot — steady transdermal delivery. Conjugated estrogens: Premarin — older, equine estrogen product used historically. Combined estrogen+progestin (historical): Prempro — conjugated estrogen + medroxyprogesterone acetate (used in the WHI study). Micronized progesterone: Prometrium — bioidentical progesterone in an FDA‑approved formulation. Vaginal/local: Vagifem (vaginal tablets), Estring (vaginal ring) — low‑dose local estrogen for vaginal dryness/UTI symptoms. Testosterone products (off‑label in many women): AndroGel, Testim — used in some women for low libido but require specialist oversight. Where to look for reliable guidance and services North American Menopause Society (NAMS) — evidence‑based guidelines about menopause and HRT. Major centers like Mayo Clinic or Cleveland Clinic patient resources — trustworthy summaries. If considering compounded BHRT, use a compounding pharmacy with recognized accreditation (e.g., ACHC or Pharmacy Compounding Accreditation Board) and a clinician experienced in menopause care. Bottom line / Practical recommendation Talk with a clinician who knows menopause management (primary care, OB‑GYN, or menopause specialist). Discuss your symptoms, personal and family risk factors (VTE, cardiovascular disease, breast cancer), and treatment goals. Prefer FDA‑approved formulations when suitable (they have known dosing, quality, and safety data). If you still consider compounded bioidentical hormones, use an accredited compounding pharmacy and close medical supervision. Don’t assume “bioidentical” = safer or “natural” = risk‑free; individualize the choice by symptoms, risks, and preferences. If you want, tell me: your main symptoms, medical history (smoking, clot history, breast cancer, etc.), and whether you prefer pills, patches or creams — I can explain which specific options might be best for you and why.

Mentioned in position 6 of 10

Read full answer with sources →
ClaudeOct 1, 2026, 11:31 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT Standard HRT These are hormone medications that may contain: Synthetic hormones (like medroxyprogesterone acetate) Animal-derived hormones (like Premarin, made from pregnant mare urine) FDA-regulated, extensively tested formulations Common brands: Premarin, Prempro, Provera Bioidentical Hormones These have a molecular structure identical to hormones your body produces naturally Two main types: FDA-approved bioidentical products - standardized, tested Compounded bioidentical hormones - custom-mixed by compounding pharmacies Key Differences Factor Standard HRT Bioidentical Molecular match May differ Identical to human hormones Regulation FDA-approved Varies widely Customization Fixed doses Can be tailored Research base Extensive Less robust Recommended FDA-Approved Bioidentical Options Estrace (estradiol) Prometrium (progesterone) Vivelle-Dot (estradiol patch) Important Advice Consult a menopause specialist or endocrinologist Be cautious with compounded hormones - quality control varies The Menopause Society (NAMS) is a good resource for finding qualified providers Would you like more specific product recommendations?

Mentioned in position 2 of 6

Read full answer with sources →

TL;DR

Prempro is a prescription hormone replacement therapy (HRT) medication combining conjugated estrogens and medroxyprogesterone acetate, used to manage symptoms of menopause in women who have a uterus. It is manufactured by Pfizer under its Upjohn legacy brands and is available through licensed pharmacies. According to WellRank's latest index, Prempro ranks first in the menopause and women's health category with 33% AI answer visibility, appearing in 48 tracked AI mentions with an overwhelmingly neutral clinical tone.

Company Overview

Prempro is a branded prescription drug rather than a standalone company; it is produced by Pfizer (formerly under the Wyeth and Upjohn banners) and sold through pharmacies and specialty compounding channels. The product's online presence at premproxy.com appears to serve as an informational or access-facilitation resource, though the specific business model of that site is not publicly disclosed. The drug itself has been on the US market for decades and is regulated by the FDA.

Product Features

  • Combination conjugated estrogens and medroxyprogesterone acetate tablet for menopausal symptom relief
  • Available in multiple dosage strengths to allow individualized prescribing
  • Indicated for vasomotor symptoms such as hot flashes and night sweats
  • Also used for prevention of postmenopausal osteoporosis in eligible patients
  • Oral daily tablet format for consistent systemic hormone delivery
  • Subject to updated FDA labeling following recent regulatory guidance on HRT warnings

Target Market

Prempro is prescribed to postmenopausal women who still have a uterus and require both estrogen and progestogen therapy. It is primarily used in the United States, where it is FDA-approved, though HRT broadly is discussed in international clinical contexts as covered by sources such as the NHS and The Menopause Charity. The target population generally includes women in perimenopause or early postmenopause experiencing moderate to severe symptoms.

Buyer Personas

  • A woman in her late 40s to mid-50s experiencing disruptive hot flashes and sleep disruption who is seeking a physician-prescribed systemic HRT option.
  • A postmenopausal woman concerned about bone density loss who is working with her gynecologist to weigh HRT's benefits against risks.
  • A primary care physician or OB-GYN looking for a well-established combination HRT reference point when counseling patients on menopause management.
  • A health-conscious woman who has researched evolving HRT safety data, including recent findings on cardiovascular safety for women under 60, and wants to discuss oral combination therapy with her provider.

Funding & Performance

Prempro is a product of Pfizer, a publicly traded global pharmaceutical company (NYSE: PFE). Revenue and sales figures specific to Prempro are not broken out publicly in Pfizer's filings. The premproxy.com platform's funding and scale are not publicly disclosed.

Recent Developments

HRT as a therapeutic category has experienced a notable clinical rehabilitation in recent years, with the FDA removing longstanding cautionary language from HRT labeling that had deterred prescribing for decades. This regulatory shift has renewed clinician and patient interest in products like Prempro, as reflected in growing media and clinical coverage. Stanford Medicine and other major academic health systems have published guidance noting that hormone therapy is making a comeback amid reassuring safety data.

Competitive Landscape

Prempro competes within a crowded HRT landscape that includes estrogen-only products such as Premarin, Estrace, and Climara, combination therapies like Prometrium and Provera, and transdermal options including Vivelle-Dot, Divigel, and Evamist. These are the brands AI engines most frequently mention alongside Prempro according to WellRank's co-mention data. The Mayo Clinic's overview of hormone therapy and resources like UCHealth discuss many of these options together, reflecting how clinicians and patients compare them side by side.

Prempro vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Prempro logo
PremproThis brand
–
0.0%
Estrace logo
Estrace

50 shared answers

#4
27.8%
Vivelle-Dot logo
Vivelle-Dot

48 shared answers

#1
33.3%
Premarin logo
Premarin

46 shared answers

#6
22.2%
Prometrium logo
Prometrium

42 shared answers

#5
27.8%

Email me when overtakes Prempro

One email the day the ranks flip. Nothing else.

User Sentiment

Of the 48 AI mentions tracked by WellRank, 42 are neutral, 4 are positive, and 2 are mixed or cautious, indicating that AI engines treat Prempro primarily as a clinical reference point rather than a brand with strong advocacy or controversy. The cautious mentions likely reflect residual awareness of older safety debates, including the Women's Health Initiative findings, which have since been substantially reframed as discussed in BCMJ's analysis of HRT in older women. Public and clinical discourse is increasingly balanced, with educational video content also cited among the sources engines draw on.

Pricing

Prempro is a prescription medication; retail pricing varies by pharmacy, dosage strength, insurance coverage, and patient assistance program eligibility. Exact out-of-pocket costs are not published in a standardized way and are not disclosed by premproxy.com in any publicly available format.

Sources cited around Prempro

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Prempro weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Prempro? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.